Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04873258

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Sponsor: Richmond Research Institute

View on ClinicalTrials.gov

Summary

A generic screening study to establish structural and/or functional baselines of specific organs.

Official title: Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Volunteers on Clinical Trials Utilising Machine-learning and Bioimpedance Vector Analysis

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

2000

Start Date

2019-09-27

Completion Date

2027-12-31

Last Updated

2025-07-23

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

Bioimpedence Vector Analysis

Bioimpedence vector analysis

Locations (1)

Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge

London, London, United Kingdom